4//SEC Filing
Gelder Mark S. MD 4
Accession 0001415889-23-002168
CIK 0001130598other
Filed
Feb 7, 7:00 PM ET
Accepted
Feb 8, 5:58 PM ET
Size
8.6 KB
Accession
0001415889-23-002168
Insider Transaction Report
Form 4
Gelder Mark S. MD
Chief Medical Officer
Transactions
- Exercise/Conversion
Common Stock
2023-02-07+5,833→ 11,729 total - Tax Payment
Common Stock
2023-02-07$1.36/sh−1,242$1,689→ 10,487 total - Exercise/Conversion
Restricted Stock Units
2023-02-07−5,833→ 11,667 total→ Common Stock (5,833 underlying)
Footnotes (2)
- [F1]Restricted stock units convert into common stock on a one-for-one basis.
- [F2]On February 7, 2022 the reporting person was granted 17,500 restricted stock units which vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34% on the third anniversary.
Documents
Issuer
Onconova Therapeutics, Inc.
CIK 0001130598
Entity typeother
Related Parties
1- filerCIK 0001564390
Filing Metadata
- Form type
- 4
- Filed
- Feb 7, 7:00 PM ET
- Accepted
- Feb 8, 5:58 PM ET
- Size
- 8.6 KB